The DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.
Global estimates on the number of persons across the Alzheimer's disease continuum
Open accessAbstract
Introduction: Global estimates on numbers of persons in early stages of Alzheimer's disease (AD), including prodromal and preclinical, are lacking, yet are needed to inform policy decisions on preventive measures and planning for future therapies targeting AD pathology. Methods: We synthesized the literature on prevalence across the AD continuum and derived a model estimating the number of persons, stratified by 5‐year age groups, sex, and disease stage (AD dementia, prodromal AD, and preclinical AD). Results: The global number of persons with AD dementia, prodromal AD, and preclinical AD were estimated at 32, 69, and 315 million, respectively. Together they constituted 416 million across the AD continuum, or 22% of all persons aged 50 and above. Discussion: Considering predementia stages, the number of persons with AD is much larger than conveyed in available literature. Our estimates are uncertain, especially for predementia stages in low‐ and middle‐income regions where biomarker studies are missing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“While this is still the subject of ongoing research, estimates are emerging of the prevalence of preclinical Alzheimer's disease in the population.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [250]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30367-6 · Cited by 10,430
RetractedMcKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Nichols, E., Steinmetz, J. D., Vollset, S. E., Fukutaki, K., Chalek, J., Abd-Allah, F., Abdoli, A., Abualhasan, A., Abu-Gharbieh, E., Akram, T. T., et al. (2022) · The Lancet Public Health · doi:10.1016/s2468-2667(21)00249-8 · Cited by 5,575
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
Dubois, B., Feldman, H. H., Jacova, C., DeKosky, S. T., Barberger-Gateau, P., Cummings, J., Delacourte, A., Galasko, D., Gauthier, S., Jicha, G., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70178-3 · Cited by 4,411
Ngandu, T., Lehtisalo, J., Solomon, A., Levälahti, E., Ahtiluoto, S., Antikainen, R., Bäckman, L., Hänninen, T., Jula, A., Laatikainen, T., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60461-5 · Cited by 3,689
Research works printed but not linked: 3
- WHO, 2019, Risk reduction of cognitive decline and dementia: WHO guidelines, Geneva: World Health Organization
- American Psychiatric Association Diagnostic and statistical manual of mental disorders.2000(4th edition).
- WHO, 2021, Global status report on the public health response to dementia, Geneva: World Health Organization
Cited by
Sorted by citations
Items 301–400 of 900
Melin, E. O., Thunander, M., Wanby, P., Holmberg, S., Thulesius, H. O., Landin‐Olsson, M., & Hillman, M. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16347 · Cited by 7
Measuring time saved in Alzheimer's disease: What is a meaningful slowing of progression?
Lanctôt, K. L., Jönsson, L., Atri, A., Paulsen, R., Mattke, S., Hahn‐Pedersen, J. H., Polavieja, P., Maltesen, T., León, T., Gustavsson, A., et al. (2025) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.70081 · Cited by 7
Self-citationChen, H., Deng, Y., Li, X., Ding, A., Wang, J., Sun, A., Tu, H., & Qiao, Y. (2025) · BMC Neurology · doi:10.1186/s12883-025-04183-8 · Cited by 7
Hajar, M., Werner, T., Gajić, M., Stark, H., & Sadek, B. S. (2025) · Medicinal Research Reviews · doi:10.1002/med.22119 · Cited by 8
Kukolj, M., Oršolić, N., Horvat, L. L., Nikolić, B., Orct, T., Branović, K., Gračan, R., Zrinščak, I., Jembrek, M. J., & Šimić, G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125743 · Cited by 7
Kang, B., Park, M. K., Kim, J. I., Yoon, S., Heo, S., Kang, C., Lee, S., Choi, Y.-S., & Hong, D. (2025) · Journal of Medical Internet Research · doi:10.2196/69379 · Cited by 6
Kotova, M. M., Stewart, A., Grigoryan, A., Shariff, S., Mirzaei, F., Kantawala, B., Dilbaryan, K., de Abreu, M. S., Galstryan, D. S., Cui, J., et al. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70090 · Cited by 7
Fu, J. F., Liang, Z., Chen, Z., Chen, W., Zhou, Y., Xiong, F., Meng, L., Liang, Q., & Gao, H. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.145531 · Cited by 7
Alzheimer’s: Epidemiology, Pathophysiology, Diagnosis, and Treatments
Rahman, A. T. F., Jaiswal, A., Keshari, P., & Singh, D. K. (2025) · Springer eBooks · doi:10.1007/978-981-96-6202-9_2 · Cited by 9
Pu, D., Ye, J., Wang, L., Wang, R., Li, L., Song, Y., & Han, X. (2025) · Neurochemistry International · doi:10.1016/j.neuint.2025.106034 · Cited by 7
Zhang, Y., Deng, L., Wei, J., Huang, L., Gao, F., Yu, L., Zhu, F., Mi, J., Wu, J., Ren, F., et al. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00721 · Cited by 8
Gut-brain nexus: Mapping multimodal links to neurodegeneration at biobank scale
Shafieinouri, M., Hong, S., Lee, P. S., Grant, S. M., Khani, M., Dadu, A., Schuh, A. F. S., Makarious, M. B., Sandon, R., Simmonds, E., et al. (2025) · Science Advances · doi:10.1126/sciadv.adu2937 · Cited by 8
The therapeutic efficacy of nanoparticles in the treatment of alzheimer’s disease
Ntondini, T. L., Naki, T., & Alven, S. (2025) · Acta Neurologica Belgica · doi:10.1007/s13760-025-02905-w · Cited by 7
Ahmad, N., Ambreen, N., Ayaz, M., Zainab, Z., Alam, A., Ahmad, I., Elhenawy, A. A., Zghab, I., Shah, S. A. A., & Ahmad, M. (2025) · Journal of Molecular Recognition · doi:10.1002/jmr.70012 · Cited by 7
Gasdermins in neurodegeneration: emerging mechanisms and therapeutic targets
Chen, S., Zhang, J., Chen, X., Lai, Z., Zhao, Z., & Wang, S.-B. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08373-7 · Cited by 8
Wang, S., Guo, Y., Wang, S., Wang, Y., Huo, S. Y., Li, M., Chen, Q., Zhang, L., Kuang, H., Juan, P., et al. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.121359 · Cited by 8
In-Depth Proteomic Analysis of De Novo Proteome in a Mouse Model of Alzheimer’s Disease
Wang, X., Zhou, X., Lee, J., Furdui, C. M., & Ma, T. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221044 · Cited by 7
Silva, N. C. B. S., ten Brinke, L. F., Bielak, A. A. M., Handy, T. C., & Liu-Ambrose, T. Y. L. (2023) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617723000577 · Cited by 8
Zhang, J., Guo, S., Tao, R., Wang, F., Xie, Y., Wang, H., Ding, L., Shen, Y., Zhou, X., Feng, J., et al. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137560 · Cited by 7
Ren, W., Yan, X.-S., Fan, J.-C., Huo, D.-S., Wang, X., Jia, J., & Yang, Z.-J. (2024) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2024.2336570 · Cited by 7
Implications of liquid-liquid phase separation and ferroptosis in Alzheimer's disease
Wang, F., Chen, Z., Zhou, Q., Sun, Q., Zheng, N., Chen, Z., Lin, J., Li, B., & Li, L. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110083 · Cited by 9
Effects of Menopause and High Fat Diet on Metabolic Outcomes in a Mouse Model of Alzheimer’s Disease
Abi‐Ghanem, C., Salinero, A. E., Smith, R. M., Kelly, R. D., Belanger, K., Richard, R., Paul, A. S., Herzog, A. A., Thrasher, C. A., Rybka, K. A., et al. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231332 · Cited by 6
Microglia-Associated Neuroinflammation in Alzheimer’s Disease and Its Therapeutic Potential
Shah, S., & Jain, H. (2024) · Neuroglia · doi:10.3390/neuroglia5040029 · Cited by 10
Zheng, H., Mizokami, A., Romera-Giner, S., Llera-Oyola, J., Yamawaki, Y., Sano, T., Jimi, E., Garcia‐García, F., & Kanematsu, T. (2025) · Biology of Sex Differences · doi:10.1186/s13293-025-00686-8 · Cited by 7
Recent Advances in Photoelectrochemical Sensing of Alzheimer’s Biomarkers
Kim, K. (2023) · BioChip Journal · doi:10.1007/s13206-023-00105-3 · Cited by 8
Bader, I., Bader, I., Alves, I. L., García, D. V., Vellas, B. J., Dubois, B., Boada, M., Marquié, M., Altomare, D., Scheltens, P., et al. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01332-4 · Cited by 9
Diagnostic performance of light reflex pupillometry in Alzheimer's disease
Gramkow, M. H., Clemmensen, F. K., Sjælland, N. S., Waldemar, G., Hasselbalch, S. G., & Frederiksen, K. S. (2024) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12628 · Cited by 7
Neurodegenerative Diseases: Molecular Mechanisms and Therapies 2nd Edition
Zhou, Z., & Kihara, A. H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111334 · Cited by 7
Nguyen‐Thi, P., Vo, T. K., Le, H. T., Nguyen, N. T. T., Nguyen, T. T., & Giau, V. V. (2024) · Pharmaceutical Research · doi:10.1007/s11095-024-03718-x · Cited by 6
Health Behavior Change to Mitigate Dementia Risk: An Updated Review
Sanborn, V. E., Davis, J. D., & Korthauer, L. E. (2024) · Current Geriatrics Reports · doi:10.1007/s13670-024-00421-y · Cited by 6
Tian, H., Lai, Z., Zhang, W., Zhang, M., Yang, X., Zhou, J., & Li, Z. (2024) · Small Methods · doi:10.1002/smtd.202400529 · Cited by 6
Ali, A., Emad, N. A., Sultana, N., Waheed, A., Aqil, M., Sultana, Y., & Mujeeb, M. (2024) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273319597240927044906 · Cited by 6
Olfactory deficits in aging and Alzheimer’s—spotlight on inhibitory interneurons
Elhabbari, K., Sireci, S., Rothermel, M., & Brunert, D. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1503069 · Cited by 7
Naveed, M., Ibrahim, S., Aziz, T. A., Khatoon, K., Asim, M., Majeed, M. N., Hussain, N., Alhomrani, M., Alsanie, W. F., & Alamri, A. S. (2025) · Journal of Computational Biophysics and Chemistry · doi:10.1142/s2737416525500085 · Cited by 6
Lau, F., Binacchi, R., Brugnara, S., Cumplido-Mayoral, A., Savino, S. D., Khan, I., Orso, A., Sartori, S., Bellosta, P., Carl, M., et al. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.03.042 · Cited by 6
Aathira, N. S., Kaur, A., Kumar, A., Dar, G. M., Nimisha, Sharma, A. K., Bera, P., Mahajan, B., Chatterjee, A., & Saluja, S. S. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.05.021 · Cited by 7
Hall, S. E., White, Z. J., Rohn, T. T., Sudasinghe, K., & Young, M. E. (2025) · Brain Sciences · doi:10.3390/brainsci15060631 · Cited by 6
Fortea, J., & Ferrer-Picón, E. (2025) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2025.2527211 · Cited by 6
Singh, P. J., Verma, B., Wells, A., Mendes, C. C., Dunn, D., Chen, Y.-N., Oh, J., Blincowe, L., Wainwright, S. M., Fischer, R., et al. (2025) · The EMBO Journal · doi:10.1038/s44318-025-00497-y · Cited by 9
A smart secure virtual reality immersive application for alzheimer’s and dementia patients
Al-Rajab, M. M., Lu, J., Amawi, S., Elmehalawy, N., Babillie, B., Alasmi, Y., Ibrahim, H. S., Ellahham, S., Sawsaa, A. F., & Zraiqat, S. A. (2025) · Scientific Reports · doi:10.1038/s41598-025-14624-6 · Cited by 6
Stothart, G., Alderman, S., Hermann, O. P., Creavin, S., & Coulthard, E. J. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf279 · Cited by 8
Jeevanandam, J., Tsenov, G., Danquah, M. K., Ruiz‐Molina, D., Boussios, S., & Ovsepian, S. V. (2025) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-025-00813-6 · Cited by 6
Sharma, A., & Singh, T. G. (2025) · Brain Research · doi:10.1016/j.brainres.2025.150047 · Cited by 7
Tu, Y., Cui, L., Zhang, Z., Wang, M., Guan, Y., Li, Y., Xie, F., & Guo, Q. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70932 · Cited by 6
Wu, J., Geng, C., Liu, L., & Tang, Y. (2025) · Medicine Plus · doi:10.1016/j.medp.2025.100112 · Cited by 8
Zhong, Y., Fan, B., Yang, X., Huang, Y., Liang, B., Zhiming, 任晓虎, Xian, H., Deng, Y., Feng, Y., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71096 · Cited by 7
Comprehensive single-cell transcriptomic atlas of microglia in Alzheimer’s disease mouse models
Liu, P., Sun, T., Yang, J., Li, H., Min, W., Zhou, X., Xiong, R., Wu, J., Huang, Y., Li, Y., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03529-z · Cited by 6
Handicraft art leisure activities and cognitive reserve
Mashinchi, G. M., McFarland, C. P., Hall, S., Strongin, D. L., Williams, G. A., & Cotter, K. A. (2023) · The Clinical Neuropsychologist · doi:10.1080/13854046.2023.2253993 · Cited by 7
Cardoso, S., Carvalho, C., Correia, S. C., & Moreira, P. I. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167222 · Cited by 6
Mollalo, A., Knox, S., Meng, J., Benitez, A. M., Lenert, L. A., & Alekseyenko, A. V. (2024) · Information · doi:10.3390/info15110688 · Cited by 6
Implications of the Gut Microbiome in Alzheimer’s Disease: A Narrative Review
Mroke, P., Goit, R., Rizwan, M., Tariq, S., Rizwan, A. W., Umer, M., Nassar, F. F., Sarria, A. J. T., Singh, D., & Baig, I. (2024) · Cureus · doi:10.7759/cureus.73681 · Cited by 7
Shah, A. J., Dar, M. Y., Adnan, M., Varma, T., Agarwal, D., Garg, P., Mir, R. H., Meena, R., & Masoodi, M. H. (2025) · Biotechnology Reports · doi:10.1016/j.btre.2025.e00881 · Cited by 7
Wang, C., Li, K., Huang, S., Liu, J., Li, S., Tu, Y., Wang, B., Zhang, P., Luo, Y., & Chen, T. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1558448 · Cited by 6
Altuna, M., García‐Sebastián, M., Ecay‐Torres, M., Saldias, J., Cañada, M., Estanga, A., López, C., Tainta, M., Iriondo, A., de Arriba, M., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14082607 · Cited by 6
Ghosh, P., Singh, R., Chatterjee, C., Kumar, A., & Singh, S. K. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2294173 · Cited by 6
Li, X., Dou, Y., Xiao, B., & Chen, Y. (2024) · Psychogeriatrics · doi:10.1111/psyg.13158 · Cited by 6
Layne, D. M., Logan, A., & Lindell, K. O. (2024) · Nursing Reports · doi:10.3390/nursrep14030130 · Cited by 6
DUB’ling down uncovers an X-linked vulnerability in Alzheimer’s disease
Paul, B. D. (2022) · Cell · doi:10.1016/j.cell.2022.09.029 · Cited by 6
Patent Analysis of Novel Therapeutic Approaches for Treating Alzheimer’s Disease 2018–2023
Saleem, F., Naz, F., & Khan, K. M. (2023) · Pharmaceutical Patent Analyst · doi:10.4155/ppa-2023-0020 · Cited by 6
Sinibaldi, A., Chiavaioli, F. E., Occhicone, A., Danz, N., Munzert, P., Baldini, F., Giannetti, A. E., & Michelotti, F. (2025) · Advanced Sensor Research · doi:10.1002/adsr.202400164 · Cited by 6
Lan, W., Dai, Y., Chen, S., Wang, S., Zhang, Y., Gu, C., Jiang, T., & Pan, Y. (2025) · Microchemical Journal · doi:10.1016/j.microc.2025.113939 · Cited by 5
Exarchos, T. P., Skolariki, K., Mahairaki, V., Lyketsos, C. G., Vlamos, P., Scarmeas, N., Dardiotis, E., & (HIAAD), O. B. O. T. H. I. A. A. D. (2025) · Brain Sciences · doi:10.3390/brainsci15060661 · Cited by 5
Gender Differences in the Effects of Exercise Interventions on Alzheimer’s Disease
Dong, Y., Shi, L., Ma, Y., Liu, Y., Sun, Y., & Jin, Q. (2025) · Brain Sciences · doi:10.3390/brainsci15080812 · Cited by 9
Desiato, G., Bosco, P., Cintoli, S., Biagi, L., Braschi, C., Nero, C. D., Minichiello, I., Noale, M., Faggiani, E., Rossi, A., et al. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.101062 · Cited by 5
Jiang, S., Tian, Z., Yang, Y., Li, X., Zhou, F., Cheng, J., Lyu, J., Gao, T., Zhang, P., Han, H., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.08.015 · Cited by 6
Evaluating the clinical evidence of TCM in Alzheimer’s disease: an evidence map perspective
Cui, S., Zhao, Y., Wang, X., Huang, Y., Ye, J., Deng, Z., Li, Y., Qin, H., Wang, L., Li, Y., et al. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1571361 · Cited by 5
Taragano, F. E., Seinhart, D. B., Epstein, P., Sylvestre, V., Barañano, C., Castro, V. O., Sánchez, V., Kilstein, A., González, R., Franco‐Trecu, V., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251375430 · Cited by 5
Palomares, D., Vanparys, A., Jorgji, J., Paître, E., Kienlen‐Campard, P., & Suelves, N. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02118-5 · Cited by 7
Zhang, L., Ge, Y., Wu, J., Wang, M., Huang, N., & Luo, Y. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01624-3 · Cited by 6
Moretti, D. V., Kuhn, E., Dubbelman, M. A., Sikkes, S. A. M., Castilhos, R. M., Chapman, S., Gifford, K. A., Butterbrod, E., & Nosheny, R. L. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70847 · Cited by 6
Lim, S., Lee, H.-S., Yoon, S., Han, J. W., Chung, J., & Yoon, S. (2025) · Translational and Clinical Pharmacology · doi:10.12793/tcp.2025.33.e19 · Cited by 5
Sex differences in Alzheimer’s disease: a systematic review of two decades of neuroimaging research
Massoumzadeh, P., Tiemann, S. J., Naghashzadeh, M., Rizzo, J., Hu, J. Y., Yaeger, L., Alkelani, H., Wang, Q., Chen, G., Dolatshahi, M., et al. (2026) · British Journal of Radiology · doi:10.1093/bjr/tqag011 · Cited by 7
Fan, S., Liu, P.-C., Wang, J.-Z., Win, N. N., Lin, C., & Lin, H.-H. (2026) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2026.03.072 · Cited by 5
Liu, M., Cui, L., Zhao, Z., Ren, S., Huang, L., Guan, Y., Guo, Q., Xie, F., Huang, Q., & Shen, D. G. (2023) · Cerebral Cortex · doi:10.1093/cercor/bhad381 · Cited by 5
Focusing on Earlier Management of Alzheimer Disease
Frederiksen, K. S., Morató, X., Zetterberg, H., Gauthier, S. G., Boada, M., Pytel, V., & Mattke, S. (2024) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000600 · Cited by 5
Veneziani, I., Grimaldi, A., Marra, A., Morini, E., Culicetto, L., Marino, S., Quartarone, A., & Maresca, G. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13082307 · Cited by 5
Woods, C., Xing, X., Khanal, S., & Lin, A. (2024) · Bioengineering · doi:10.3390/bioengineering11090943 · Cited by 5
Tristão‐Pereira, C., Fuster, V., López‐Jiménez, A., Fernández‐Pena, A., Semerano, A., Fernandez‐Nueda, I., García‐Lunar, I., Ayuso, C., Sánchez‐Gonzalez, J., Ibáñez, B., et al. (2024) · American Heart Journal · doi:10.1016/j.ahj.2024.09.028 · Cited by 5
Yabo-Dambagi, L., Cakir, A., & Karaküçük‐İyidoğan, A. (2024) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162024050078 · Cited by 5
Wang, W., Zhang, J., & Li, C. (2024) · The International Journal of Psychiatry in Medicine · doi:10.1177/00912174241290962 · Cited by 6
Interactive AI Technology for Dementia Caregivers: Needs and Implementation Evidence
Sun, F., Jiang, L. H., Chen, X. S., & Feng, Y. (2025) · Journal of Technology in Human Services · doi:10.1080/15228835.2025.2460156 · Cited by 5
Implications of Mucin-Type O-Glycosylation in Alzheimer’s Disease
Navarro, N. V., Mundim, G. D. N., & Čudić, M. (2025) · Molecules · doi:10.3390/molecules30091895 · Cited by 5
Alzheimer's disease and vascular biology – A focus on the procoagulant state
Casquero‐Veiga, M., Cerón, C., & Cortés‐Canteli, M. (2025) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2025.102528 · Cited by 6
Villalpando, J. M., Leclerc, B., Le, M. T., Hudon, C., Bolduc, A., & Kergoat, M. (2025) · Neuropsychology Review · doi:10.1007/s11065-025-09663-9 · Cited by 6
Taha, H. B., Chawla, E., & Bitan, G. (2023) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.3c00065 · Cited by 4
Advancements in Single-Cell RNA Sequencing Research for Neurological Diseases
Yang, B., Hu, S., Jiang, Y., Xu, L., Shu, S., & Zhang, H. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04126-3 · Cited by 6
Wimo, A. B., Kirsebom, B., Reina, S. T., Vromen, E., Selnes, P., Bon, J., Emeršič, A., Kramberger, M. G., Špeh, A., Visser, P. J., et al. (2024) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.6126 · Cited by 5
Wang, J., Yang, J., Lu, J., Lu, J., Bai, L., Song, Y., & Chen, G. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04701-2 · Cited by 5
Hayek-Orduz, Y., Castro, D. A. A., Escobar, J. S. S., Ortiz-Domínguez, B. E., Villegas-Torres, M. F., Caicedo, P. A., Barrera-Ocampo, A. A., Cortés, N., Osorio, E. H., & Barrios, A. F. G. (2025) · Frontiers in Chemistry · doi:10.3389/fchem.2025.1479763 · Cited by 5
Yang, J. C., Kuo, P., Chang, C., Wang, Y., Ou, Y., Cheng, Y., Wu, S., Chien, P., Hsieh, C., & Lin, W. (2025) · Plastic & Reconstructive Surgery Global Open · doi:10.1097/gox.0000000000006955 · Cited by 5
Lecanemab: The Price of a Breakthrough
Wimo, A. B., Jönsson, L., Johansson, G., & Winblad, B. G. (2023) · touchREVIEWS in Neurology · doi:10.17925/usn.2023.19.1.14 · Cited by 5
Oxidative Stress, Neuroinflammation and Neurodegeneration: The Chicken, the Egg and the Dinosaur
Quinn, P. M. J., Ambrósio, A. F., & Alves, C. H. (2022) · Antioxidants · doi:10.3390/antiox11081554 · Cited by 5
Willett, J., Waqas, M., Choi, Y., Ngai, T., Mullin, K., Tanzi, R. E., & Prokopenko, D. (2024) · medRxiv · doi:10.1101/2024.09.11.24313439 · Cited by 5
Li, X., Yan, X.-S., Zhang, C.-J., Zhang, Y., Su, X.-J., Zhang, H., Yang, J., Zhang, Y., & Zhao, Z. (2025) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2025.2474634 · Cited by 4
Zhou, Q., Huang, X., Chen, Z., Wang, F., Xie, L., Sun, Q., Du, J., Lin, J., Li, B., & Li, L. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149680 · Cited by 5
Sharma, N., & An, S. S. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136468 · Cited by 5
Utilizing MCID for evaluating clinical relevance of AD therapeutic interventions
Hamilton, J. L., Fuller, R. L. M., Modi, N., & Sampaio, C. (2025) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.70138 · Cited by 4
2′-Fucosyllactose Ameliorates Cognitive Impairment and Neuroinflammation in AD Mice
Ma, Y., Zhang, M., Jin, Y., Wang, Y., Ji, T., Wu, F., Li, Y., Wang, R., Guo, H., Ren, F., et al. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c06137 · Cited by 4
Ribas, G. G., & Ferrer-Picón, E. (2025) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2025.2576520 · Cited by 5
The challenging concept of preclinical Alzheimer's disease
Wallon, D., & Garnier‐Crussard, A. (2025) · Revue Neurologique · doi:10.1016/j.neurol.2025.07.016 · Cited by 6
Metadata
- Authors
- Gustavsson, A., Norton, N., Fast, T., Frölich, L., Georges, J., Holzapfel, D., Kirabali, T., Krolak‐Salmon, P., Rossini, P. M., Ferretti, M. T., Lanman, L., Chadha, A. S., & van der Flier, W. M.
- Affiliations
- Karolinska Institutet (SE)
- Quantify Research (Sweden) (SE)
- Heidelberg University (DE)
- Alzheimer Europe (LU)
- CEO Initiative on Alzheimer's Disease Philadelphia USA
- Biogen (Switzerland) (CH)
- Hospices Civils de Lyon (FR)
- Università Cattolica del Sacro Cuore (IT)
- Women's Brain Project (CH)
- F. Hoffmann-La Roche AG (CH)
- Alzheimer Center Amsterdam Department of Neurology Department of Epidemiology and Data Science Amsterdam Neuroscience Amsterdam UMC, Vrije Universiteit Amsterdam Amsterdam the Netherlands
- Corresponding author
- Gustavsson, Anders
- ORCID
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2022-06-02
- Volume
- 19
- Issue
- 2
- Pages
- 658-670
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W4281674975
- Cited by
- 895
- References
- 62
- Citations by year
- 2026: 207 · 2025: 323 · 2024: 236 · 2023: 114 · 2022: 15
- FWCI
- 112.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Alzheimer s & Dementia (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Funders
- F. Hoffmann-La Roche
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
- Keywords
- Alzheimer's disease, Alzheimer's disease continuum
- MeSH terms
- Alzheimer Disease, Humans, Biomarkers, Prevalence, Prodromal Symptoms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
